dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2020-12-12T02:49:05Z
dc.date.accessioned2022-12-19T21:24:03Z
dc.date.available2020-12-12T02:49:05Z
dc.date.available2022-12-19T21:24:03Z
dc.date.created2020-12-12T02:49:05Z
dc.date.issued2020-10-01
dc.identifierPharmaceutical Research, v. 37, n. 10, 2020.
dc.identifier1573-904X
dc.identifier0724-8741
dc.identifierhttp://hdl.handle.net/11449/202070
dc.identifier10.1007/s11095-020-02917-6
dc.identifier2-s2.0-85090324222
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5382704
dc.description.abstractInfectious diseases are a major global concern being responsible for high morbidity and mortality mainly due to the development and enhancement of multidrug-resistant microorganisms exposing the fragility of medicines and vaccines commonly used to these treatments. Taking into account the scarcity of effective formulation to treat infectious diseases, nanotechnology offers a vast possibility of ground-breaking platforms to design new treatment through smart nanostructures for drug delivery purposes. Among the available nanosystems, mesoporous silica nanoparticles (MSNs) stand out due their multifunctionality, biocompatibility and tunable properties make them emerging and actual nanocarriers for specific and controlled drug release. Considering the high demand for diseases prevention and treatment, this review exploits the MSNs fabrication and their behavior in biological media besides highlighting the most of strategies to explore the wide MSNs functionality as engineered, smart and effective controlled drug release nanovehicles for infectious diseases treatment. [Figure not available: see fulltext.].
dc.languageeng
dc.relationPharmaceutical Research
dc.sourceScopus
dc.subjectbiological behavior
dc.subjectdrug delivery
dc.subjectinfectious diseases
dc.subjectmesoporous silica nanoparticles
dc.subjectmultifunctional nanocarriers
dc.titleHighlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución